Last update 01 Nov 2024

DCBCI-0901

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [1]
Target
PI3Kα x mTORC1 x mTORC2
Mechanism
PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors), mTORC1 inhibitors(Mammalian target of Rapamycin (mTORC1) inhibitors), mTORC2 inhibitors(mTOR Complex 2 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication
Advanced Malignant Solid Neoplasm
Originator Organization
Standard Chemical & Pharmaceutical Co., Ltd.Standard Chemical & Pharmaceutical Co., Ltd.
Active Organization
Development Center for BiotechnologyDevelopment Center for Biotechnology
Inactive Organization
Standard Chemical & Pharmaceutical Co., Ltd.Standard Chemical & Pharmaceutical Co., Ltd.
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with DCBCI-0901
NCT02151357 / TerminatedPhase 1
Phase I, Sequential Dose Escalation Clinical Study to Investigate the Safety, Tolerability and Pharmacokinetics of in Patients With Advanced Solid Tumor
100 Clinical Results associated with DCBCI-0901
Login to view more data
100 Translational Medicine associated with DCBCI-0901
Login to view more data
100 Patents (Medical) associated with DCBCI-0901
Login to view more data
100 Deals associated with DCBCI-0901
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPreclinical
TW
Standard Chemical & Pharmaceutical Co., Ltd.Standard Chemical & Pharmaceutical Co., Ltd.
19 Aug 2014
NeoplasmsPreclinical
TW
Development Center for BiotechnologyDevelopment Center for Biotechnology
01 Nov 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free